Professor Paul Glare MBBS, FRACP, FFPM ANZCA, FAChPM RACP, MA Applied Ethics (Healthcare), MMed (Clin Epidemiol)
- Pain Specialist
- Chair in Pain Medicine, Sydney Medical School, University of Sydney- Northern Clinical School
- Head, Discipline of Pain Medicine, Sydney Medical School
- Director, Pain Management & Research Institute, Faculty of Medicine, University of Sydney
- Board member, painaustralia
Prior to his current appointments, Paul was Chief of the Pain & Palliative Care Service, Memorial Sloan Kettering Cancer Center in New York from 2008 to 2016, with an affiliated appointment as Professor of Medicine at Weill Cornell Medical College.
After graduating from University of Sydney’s Medical School in 1981, Professor Glare undertook physician training at Royal Prince Alfred Hospital during which time he developed an interest in cancer pain and palliative care. Subsequently, he spent 2 years as a research fellow (working on opioid pharmacology in cancer pain) at the Cleveland Clinic, Ohio USA before returning to Sydney in 1991 as staff specialist in palliative care until he moved to New York in 2008. He was made a Foundation Fellow of the Faculty of Pain Medicine in 2000.
His two current research interests are pain in cancer survivors, and the decision architecture of pain management, in particular tapering of opioids.
PRESENTATION TITLE: Psychosocial Dimensions of Pain in Cancer Survivors
It is estimated some 3-4 people per 1000 population is living with moderate-severe pain following cancer treatment. Historically, opioids have been the main treatment for alleviating cancer-related pain but their role in chronic pain management is limited. Cancer survivors are living longer and opioids may also cause immunosuppression and tumorogenesis. Consequently, alternative approaches to treating chronic pain in cancer survivors are urgently needed. Data from the electronic Persistent Pain Outcomes Collaboration indicate cancer patients may have similar unhelpful thoughts towards coping with pain as people with other kinds of chronic pain. This suggests they may benefit from learning pain self-management strategies that they can use instead of taking drugs. This talk will present some data supporting this approach and discuss the facilitators and barriers to adopting it.